skip to main content
Idioma:
Refinado por: assunto: Middle Aged remover Clinical Cancer Research remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy
Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy

Madan, Ravi A ; Gulley, James L ; Schlom, Jeffrey ; Steinberg, Seth M ; Liewehr, David J ; Dahut, William L ; Arlen, Philip M

Clinical cancer research, 2008-07, Vol.14 (14), p.4526-4531 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
2
Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer
Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer

MIELKE, Stephan ; SPARREBOOM, Alex ; STEINBERG, Seth M ; GELDERBLOM, Hans ; UNGER, Clemens ; BEHRINGER, Dirk ; MROSS, Klaus

Clinical cancer research, 2005-07, Vol.11 (13), p.4843-4850 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
3
BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer
BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer

ANNUNZIATA, Christina M ; KLEINBERG, Lilach ; DAVIDSON, Ben ; BERNER, Aasmund ; GIUS, David ; TCHABO, Nana ; STEINBERG, Seth M ; KOHN, Elise C

Clinical cancer research, 2007-11, Vol.13 (22), p.6585-6592 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
4
Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma
Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma

PIEKARZ, Richard L ; FRYE, A. Robin ; WRIGHT, John J ; STEINBERG, Seth M ; LIEWEHR, David J ; ROSING, Douglas R ; SACHDEV, Vandana ; FOJO, Tito ; BATES, Susan E

Clinical cancer research, 2006-06, Vol.12 (12), p.3762-3773 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
5
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer

Portera, Chia C ; Walshe, Janice M ; Rosing, Douglas R ; Denduluri, Neelima ; Berman, Arlene W ; Vatas, Ujala ; Velarde, Margarita ; Chow, Catherine K ; Steinberg, Seth M ; Nguyen, Diana ; Yang, Sherry X ; Swain, Sandra M

Clinical cancer research, 2008-05, Vol.14 (9), p.2710 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Chalfin, Heather J ; Pramparo, Tiziano ; Mortazavi, Amir ; Niglio, Scot A ; Schonhoft, Joseph D ; Jendrisak, Adam ; Chu, Yen-Lin ; Richardson, Robin ; Krupa, Rachel ; Anderson, Amanda K L ; Wang, Yipeng ; Dittamore, Ryan ; Pal, Sumanta K ; Lara, Primo N ; Stein, Mark N ; Quinn, David I ; Steinberg, Seth M ; Cordes, Lisa M ; Ley, Lisa ; Mallek, Marissa ; Sierra Ortiz, Olena ; Costello, Rene ; Cadena, Jacqueline ; Diaz, Carlos ; Gulley, James L ; Dahut, William L ; Streicher, Howard ; Wright, John J ; Trepel, Jane B ; Bottaro, Donald P ; Apolo, Andrea B

Clinical cancer research, 2021-03, Vol.27 (5), p.1391-1398 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin

SCHRUMP, David S ; FISCHETTE, Maria R ; WRIGHT, John J ; ROSING, Douglas R ; SPARREBOOM, Alex ; FIGG, William D ; STEINBERG, Seth M ; NGUYEN, Dao M ; MING ZHAO ; XINMIN LI ; KUNST, Tricia F ; HANCOX, Ana ; HONG, Julie A ; CHEN, G. Aaron ; KRUCHIN, Evgeny

Clinical cancer research, 2008-01, Vol.14 (1), p.188-198 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
8
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Lampert, Erika J ; Zimmer, Alexandra ; Padget, Michelle ; Cimino-Mathews, Ashley ; Nair, Jayakumar R ; Liu, Yingmiao ; Swisher, Elizabeth M ; Hodge, James W ; Nixon, Andrew B ; Nichols, Erin ; Bagheri, Mohammad H ; Levy, Elliott ; Radke, Marc R ; Lipkowitz, Stanley ; Annunziata, Christina M ; Taube, Janis M ; Steinberg, Seth M ; Lee, Jung-Min

Clinical cancer research, 2020-08, Vol.26 (16), p.4268-4279 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

GULLEY, James L ; ARLEN, Philip M ; CAMPHAUSEN, Kevin ; COLEMAN, C. Norman ; SULLIVAN, Francis ; STEINBERG, Seth M ; SCHLOM, Jeffrey ; DAHUT, William ; BASTIAN, Anne ; MORIN, Steven ; MARTE, Jennifer ; BEETHAM, Patricia ; TSANG, Kwong-Yok ; YOKOKAWA, Junko ; HODGE, James W ; MENARD, Cynthia

Clinical cancer research, 2005-05, Vol.11 (9), p.3353-3362 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity

Kreitman, Robert J ; Stetler-Stevenson, Maryalice ; Jaffe, Elaine S ; Conlon, Kevin C ; Steinberg, Seth M ; Wilson, Wyndham ; Waldmann, Thomas A ; Pastan, Ira

Clinical cancer research, 2016-01, Vol.22 (2), p.310-318 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.